Header Logo

Connection

ROBERT KRANCE to Humans

Back to Details
This is a "connection" page, showing publications ROBERT KRANCE has written about Humans.
ROBERT KRANCE
Connection Strength
0.572
Humans
  1. Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival. Blood Adv. 2023 05 09; 7(9):1823-1830.
    View in: PubMed
    Score: 0.022
  2. Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients. Blood Adv. 2019 09 24; 3(18):2689-2695.
    View in: PubMed
    Score: 0.017
  3. Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma. Pediatr Transplant. 2018 08; 22(5):e13210.
    View in: PubMed
    Score: 0.015
  4. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant. Pediatr Transplant. 2015 Jun; 19(4):391-8.
    View in: PubMed
    Score: 0.012
  5. Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies. Biol Blood Marrow Transplant. 2015 Jul; 21(7):1266-72.
    View in: PubMed
    Score: 0.012
  6. Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease. J Allergy Clin Immunol. 2012 Jan; 129(1):176-83.
    View in: PubMed
    Score: 0.010
  7. Children with acute leukemia: a comparison of outcomes from allogeneic blood stem cell and bone marrow transplantation. Pediatr Blood Cancer. 2011 Jan; 56(1):143-51.
    View in: PubMed
    Score: 0.009
  8. Stem cell transplantation in childhood non-Hodgkin's lymphomas. Curr Hematol Malig Rep. 2010 Oct; 5(4):192-9.
    View in: PubMed
    Score: 0.009
  9. Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution. Leuk Lymphoma. 2010 Apr; 51(4):664-70.
    View in: PubMed
    Score: 0.009
  10. The costs and cost-effectiveness of allogeneic peripheral blood stem cell transplantation versus bone marrow transplantation in pediatric patients with acute leukemia. Biol Blood Marrow Transplant. 2010 Sep; 16(9):1272-81.
    View in: PubMed
    Score: 0.009
  11. Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen. Biol Blood Marrow Transplant. 2008 Nov; 14(11):1245-52.
    View in: PubMed
    Score: 0.008
  12. Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine. Biol Blood Marrow Transplant. 2008 Nov; 14(11):1298-304.
    View in: PubMed
    Score: 0.008
  13. Transplantation for children with acute lymphoblastic leukemia. Bone Marrow Transplant. 2008 Aug; 42 Suppl 1:S25-S27.
    View in: PubMed
    Score: 0.008
  14. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant. 2006 Dec; 12(12):1277-84.
    View in: PubMed
    Score: 0.007
  15. Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years. Blood Adv. 2026 Jan 13; 10(1):168-180.
    View in: PubMed
    Score: 0.007
  16. Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor-alpha blockade. Pediatrics. 2005 Sep; 116(3):767-70.
    View in: PubMed
    Score: 0.006
  17. Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors. Pediatr Blood Cancer. 2025 Apr; 72(4):e31557.
    View in: PubMed
    Score: 0.006
  18. Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytes. Transplantation. 2004 Sep 15; 78(5):755-7.
    View in: PubMed
    Score: 0.006
  19. Haematopoietic stem cell transplantation for autoimmune disorders: the American perspective. Br J Haematol. 2004 Sep; 126(5):637-49.
    View in: PubMed
    Score: 0.006
  20. Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors. Cytotherapy. 2024 Sep; 26(9):1026-1032.
    View in: PubMed
    Score: 0.006
  21. Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab. Pediatr Hematol Oncol. 2024 May; 41(4):260-272.
    View in: PubMed
    Score: 0.006
  22. Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia. Transplant Cell Ther. 2024 02; 30(2):217-227.
    View in: PubMed
    Score: 0.006
  23. Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantation. JCI Insight. 2023 05 22; 8(10).
    View in: PubMed
    Score: 0.005
  24. Complement-fixing CD45 monoclonal antibodies to facilitate stem cell transplantation in mouse and man. Ann N Y Acad Sci. 2003 May; 996:80-8.
    View in: PubMed
    Score: 0.005
  25. Hematopoietic and immunomodulatory effects of lytic CD45 monoclonal antibodies in patients with hematologic malignancy. Biol Blood Marrow Transplant. 2003 Apr; 9(4):273-81.
    View in: PubMed
    Score: 0.005
  26. Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting. Clin Cancer Res. 2023 01 17; 29(2):324-330.
    View in: PubMed
    Score: 0.005
  27. Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant?in patients with ALL. Blood. 2022 04 28; 139(17):2706-2711.
    View in: PubMed
    Score: 0.005
  28. A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation. Blood Adv. 2022 03 22; 6(6):1866-1878.
    View in: PubMed
    Score: 0.005
  29. Acute exacerbation of graft-versus-host disease following SARS-CoV2 infection after hematopoietic stem cell transplant in two pediatric patients. Pediatr Blood Cancer. 2022 10; 69(10):e29661.
    View in: PubMed
    Score: 0.005
  30. Guillain-Barr? syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002 Mar; 29(6):515-7.
    View in: PubMed
    Score: 0.005
  31. Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma. Bone Marrow Transplant. 2022 04; 57(4):579-585.
    View in: PubMed
    Score: 0.005
  32. HSCT corrects primary immunodeficiency and immune dysregulation in patients with POMP-related autoinflammatory disease. Blood. 2021 11 11; 138(19):1896-1901.
    View in: PubMed
    Score: 0.005
  33. Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients. J Clin Immunol. 2021 10; 41(7):1633-1647.
    View in: PubMed
    Score: 0.005
  34. Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children's Hospital experience. Bone Marrow Transplant. 2021 11; 56(11):2797-2803.
    View in: PubMed
    Score: 0.005
  35. Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases. J Clin Oncol. 2001 Jun 01; 19(11):2804-11.
    View in: PubMed
    Score: 0.005
  36. Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant. Blood. 2021 05 13; 137(19):2585-2597.
    View in: PubMed
    Score: 0.005
  37. BK Virus Epidemiology, Risk Factors, and Clinical Outcomes: An Analysis of Hematopoietic Stem Cell Transplant Patients at Texas Children's Hospital. J Pediatric Infect Dis Soc. 2021 Apr 30; 10(4):492-501.
    View in: PubMed
    Score: 0.005
  38. Factors Impacting Time to Engraftment in Patients With High-risk Neuroblastoma Following Autologous Stem Cell Transplant. J Pediatr Hematol Oncol. 2020 10; 42(7):e569-e574.
    View in: PubMed
    Score: 0.005
  39. Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups. Blood. 2020 04 23; 135(17):1428-1437.
    View in: PubMed
    Score: 0.004
  40. Incorporation of thiotepa in a reduced intensity conditioning regimen may improve engraftment after transplant for HLH. Br J Haematol. 2020 03; 188(6):e84-e87.
    View in: PubMed
    Score: 0.004
  41. Toward Functional Immune Monitoring in Allogeneic Stem Cell Transplant Recipients. Biol Blood Marrow Transplant. 2020 05; 26(5):911-919.
    View in: PubMed
    Score: 0.004
  42. Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies. Bone Marrow Transplant. 1999 Oct; 24(7):735-9.
    View in: PubMed
    Score: 0.004
  43. T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T Cells. Clin Cancer Res. 2019 12 15; 25(24):7340-7350.
    View in: PubMed
    Score: 0.004
  44. "Mini" bank of only 8 donors supplies CMV-directed T cells to diverse recipients. Blood Adv. 2019 09 10; 3(17):2571-2580.
    View in: PubMed
    Score: 0.004
  45. Purtscher-like retinopathy: A rare presentation of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Pediatr Transplant. 2019 03; 23(2):e13344.
    View in: PubMed
    Score: 0.004
  46. Monozygotic twins with non-Down syndrome associated MLL-rearranged hematologic malignancy and megakaryoblastic differentiation. Leuk Lymphoma. 2019 04; 60(4):1083-1086.
    View in: PubMed
    Score: 0.004
  47. Immunoglobulin prophylaxis in pediatric hematopoietic stem cell transplant. Pediatr Blood Cancer. 2018 12; 65(12):e27348.
    View in: PubMed
    Score: 0.004
  48. Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience. Biol Blood Marrow Transplant. 2019 01; 25(1):157-162.
    View in: PubMed
    Score: 0.004
  49. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis. Blood. 2018 07 05; 132(1):89-100.
    View in: PubMed
    Score: 0.004
  50. High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease. Biol Blood Marrow Transplant. 2018 08; 24(8):1643-1650.
    View in: PubMed
    Score: 0.004
  51. Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives-A Single-Center Experience, 2008 to 2016. Biol Blood Marrow Transplant. 2018 07; 24(7):1424-1431.
    View in: PubMed
    Score: 0.004
  52. Intravesicular cidofovir for BK hemorrhagic cystitis in pediatric patients after hematopoietic stem cell transplant. Pediatr Transplant. 2018 05; 22(3):e13141.
    View in: PubMed
    Score: 0.004
  53. BMT beats autoimmune disease. Nat Med. 1998 Feb; 4(2):153-5.
    View in: PubMed
    Score: 0.004
  54. Hepatic arterial resistance index--an indicator of diffuse liver disease in children treated with bone marrow transplantation. Clin Radiol. 1997 Dec; 52(12):903-6.
    View in: PubMed
    Score: 0.004
  55. Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome. Biol Blood Marrow Transplant. 2018 03; 24(3):537-541.
    View in: PubMed
    Score: 0.004
  56. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2. Blood. 2017 12 14; 130(24):2682-2688.
    View in: PubMed
    Score: 0.004
  57. Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation. J Clin Oncol. 2017 Nov 01; 35(31):3547-3557.
    View in: PubMed
    Score: 0.004
  58. Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma. Oncotarget. 2017 Jul 11; 8(28):46065-46070.
    View in: PubMed
    Score: 0.004
  59. Loss of the DEK-CAN fusion transcript in a child with t(6;9) acute myeloid leukemia following chemotherapy and allogeneic bone marrow transplantation. Leukemia. 1997 Feb; 11(2):299-300.
    View in: PubMed
    Score: 0.004
  60. Prognostic factors in the acute lymphoid and myeloid leukemias of infants. Leukemia. 1996 Jun; 10(6):952-6.
    View in: PubMed
    Score: 0.003
  61. Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes. J Allergy Clin Immunol. 2016 05; 137(5):1498-1505.e1.
    View in: PubMed
    Score: 0.003
  62. Pulmonary complications after bone marrow transplantation. Radiol Clin North Am. 1996 Jan; 34(1):97-117.
    View in: PubMed
    Score: 0.003
  63. Portal venous Doppler findings in a bone marrow transplant patient with cardiac tamponade. J Ultrasound Med. 1995 Nov; 14(11):877-9.
    View in: PubMed
    Score: 0.003
  64. Risk-Based Therapy for Localized Osteosarcoma. Pediatr Blood Cancer. 2016 Mar; 63(3):412-7.
    View in: PubMed
    Score: 0.003
  65. Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation. Blood. 2015 Jun 25; 125(26):4103-13.
    View in: PubMed
    Score: 0.003
  66. CMV-specific T cells generated from na?ve T cells recognize atypical epitopes and may be protective in vivo. Sci Transl Med. 2015 Apr 29; 7(285):285ra63.
    View in: PubMed
    Score: 0.003
  67. Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning. Br J Haematol. 2015 Jun; 169(5):711-8.
    View in: PubMed
    Score: 0.003
  68. Noroviruses as a Cause of Diarrhea in Immunocompromised Pediatric Hematopoietic Stem Cell and Solid Organ Transplant Recipients. Am J Transplant. 2015 Jul; 15(7):1874-81.
    View in: PubMed
    Score: 0.003
  69. Opportunities and challenges of proteomics in pediatric patients: circulating biomarkers after hematopoietic stem cell transplantation as a successful example. Proteomics Clin Appl. 2014 Dec; 8(11-12):837-50.
    View in: PubMed
    Score: 0.003
  70. Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells. Mol Ther. 2015 Jan; 23(1):179-83.
    View in: PubMed
    Score: 0.003
  71. Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):858-62.
    View in: PubMed
    Score: 0.003
  72. Complete hematologic remissions induced by 2-chlorodeoxyadenosine in children with newly diagnosed acute myeloid leukemia. Blood. 1994 Aug 15; 84(4):1237-42.
    View in: PubMed
    Score: 0.003
  73. Successful treatment of post-transplant thrombocytopenia with romiplostim in a pediatric patient with X-linked chronic granulomatous disease. Pediatr Transplant. 2014 Nov; 18(7):E252-4.
    View in: PubMed
    Score: 0.003
  74. Outcomes after hematopoietic stem cell transplantation for children with I-cell disease. Biol Blood Marrow Transplant. 2014 Nov; 20(11):1847-51.
    View in: PubMed
    Score: 0.003
  75. Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci Transl Med. 2014 Jun 25; 6(242):242ra83.
    View in: PubMed
    Score: 0.003
  76. PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia. Am J Hum Genet. 2014 Jul 03; 95(1):96-107.
    View in: PubMed
    Score: 0.003
  77. Symptom prevalence and physiologic biomarkers among adolescents using a mobile phone intervention following hematopoietic stem cell transplantation. Oncol Nurs Forum. 2014 May; 41(3):229-36.
    View in: PubMed
    Score: 0.003
  78. Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene. Blood. 2014 Jun 19; 123(25):3895-905.
    View in: PubMed
    Score: 0.003
  79. Systemic inflammatory response syndrome after administration of unmodified T lymphocytes. Mol Ther. 2014 Jun; 22(6):1134-1138.
    View in: PubMed
    Score: 0.003
  80. Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity. Clin Cancer Res. 2014 Apr 15; 20(8):2215-25.
    View in: PubMed
    Score: 0.003
  81. Gene marking after bone marrow transplantation. Eur J Cancer. 1994; 30A(8):1171-6.
    View in: PubMed
    Score: 0.003
  82. Tretinoin toxicity in children with acute promyelocytic leukaemia. Lancet. 1993 Dec 04; 342(8884):1394-5.
    View in: PubMed
    Score: 0.003
  83. Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy. Clin Exp Immunol. 2013 Oct; 174(1):89-96.
    View in: PubMed
    Score: 0.003
  84. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study. Blood. 2013 Oct 24; 122(17):2965-73.
    View in: PubMed
    Score: 0.003
  85. Feasibility of a symptom management intervention for adolescents recovering from a hematopoietic stem cell transplant. Cancer Nurs. 2013 Sep-Oct; 36(5):394-9.
    View in: PubMed
    Score: 0.003
  86. Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant. Mol Ther. 2013 Nov; 21(11):2113-21.
    View in: PubMed
    Score: 0.003
  87. Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant. 2013 Aug; 19(8):1238-43.
    View in: PubMed
    Score: 0.003
  88. Significant morbidity and mortality attributable to rothia mucilaginosa infections in children with hematological malignancies or following hematopoietic stem cell transplantation. Pediatr Hematol Oncol. 2013 Aug; 30(5):445-54.
    View in: PubMed
    Score: 0.003
  89. Anti-pan T lymphocyte ricin A chain immunotoxin (H65-RTA) and methylprednisolone for acute GVHD prophylaxis following allogeneic BMT from HLA-identical sibling donors. Bone Marrow Transplant. 1993 Jan; 11(1):33-6.
    View in: PubMed
    Score: 0.003
  90. Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia. Blood. 2012 Jun 21; 119(25):6155-61.
    View in: PubMed
    Score: 0.003
  91. t(12;17)(p13;q21) in early pre-B acute lymphoid leukemia. Leukemia. 1992 Apr; 6(4):251-5.
    View in: PubMed
    Score: 0.003
  92. Chronic rotavirus infection in an infant with severe combined immunodeficiency: successful treatment by hematopoietic stem cell transplantation. Clin Immunol. 2012 Mar; 142(3):399-401.
    View in: PubMed
    Score: 0.002
  93. Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med. 2011 Nov 03; 365(18):1673-83.
    View in: PubMed
    Score: 0.002
  94. Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised children and healthy adults. Antimicrob Agents Chemother. 2011 Dec; 55(12):5770-9.
    View in: PubMed
    Score: 0.002
  95. Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised adolescents and healthy adults. Antimicrob Agents Chemother. 2011 Dec; 55(12):5780-9.
    View in: PubMed
    Score: 0.002
  96. Early versus delayed diagnosis of SCID: triumph versus tragedy. Clin Immunol. 2011 Jun; 139(3):360-2.
    View in: PubMed
    Score: 0.002
  97. A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group study. Cancer. 1991 Feb 01; 67(3):550-6.
    View in: PubMed
    Score: 0.002
  98. Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patients. Blood. 2011 Mar 03; 117(9):2728-34.
    View in: PubMed
    Score: 0.002
  99. Phase I evaluation of diaziquone in childhood cancer. A Pediatric Oncology Group study. Invest New Drugs. 1990 May; 8(2):167-70.
    View in: PubMed
    Score: 0.002
  100. Reduced-intensity conditioning regimens for allogeneic transplantation in children with acute lymphoblastic leukemia. Biol Blood Marrow Transplant. 2010 Sep; 16(9):1237-44.
    View in: PubMed
    Score: 0.002
  101. Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning. J Allergy Clin Immunol. 2009 Nov; 124(5):1062-9.e1-4.
    View in: PubMed
    Score: 0.002
  102. Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood. 2009 Nov 05; 114(19):4283-92.
    View in: PubMed
    Score: 0.002
  103. Overexpression of ZNF342 by juxtaposition with MPO promoter/enhancer in the novel translocation t(17;19)(q23;q13.32) in pediatric acute myeloid leukemia and analysis of ZNF342 expression in leukemia. Genes Chromosomes Cancer. 2009 Jun; 48(6):480-9.
    View in: PubMed
    Score: 0.002
  104. A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET. Neuro Oncol. 2009 Feb; 11(1):33-40.
    View in: PubMed
    Score: 0.002
  105. Total-body irradiation and high-dose teniposide: a pilot study in bone marrow transplantation for patients with relapsed acute lymphoblastic leukemia. Cancer Treat Rep. 1987 Jun; 71(6):645-7.
    View in: PubMed
    Score: 0.002
  106. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum. 2006 Dec; 54(12):3750-60.
    View in: PubMed
    Score: 0.002
  107. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. 2006 Oct; 7(10):813-20.
    View in: PubMed
    Score: 0.002
  108. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med. 2006 Oct; 12(10):1160-6.
    View in: PubMed
    Score: 0.002
  109. Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation. Blood. 2006 Sep 15; 108(6):1797-808.
    View in: PubMed
    Score: 0.002
  110. Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML). Bone Marrow Transplant. 2006 Mar; 37(6):547-52.
    View in: PubMed
    Score: 0.002
  111. Bone marrow transplantation for acute nonlymphocytic leukemia in first remission: analysis of prognostic factors. Blood. 1985 Dec; 66(6):1488.
    View in: PubMed
    Score: 0.002
  112. Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transplant. 2005 Dec; 36(11):1001-8.
    View in: PubMed
    Score: 0.002
  113. Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab. Bone Marrow Transplant. 2005 Nov; 36(9):797-802.
    View in: PubMed
    Score: 0.002
  114. Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children. Biol Blood Marrow Transplant. 2005 Nov; 11(11):912-20.
    View in: PubMed
    Score: 0.002
  115. Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation. Blood. 2006 Feb 15; 107(4):1332-41.
    View in: PubMed
    Score: 0.002
  116. CD52 and CD45 monoclonal antibodies for reduced intensity hemopoietic stem cell transplantation from HLA matched and one antigen mismatched unrelated donors. Bone Marrow Transplant. 2005 Jun; 35(12):1127-32.
    View in: PubMed
    Score: 0.002
  117. Acute lymphoblastic leukemia in a patient with Greig cephalopolysyndactyly and interstitial deletion of chromosome 7 del(7)(p11.2 p14) involving the GLI3 and ZNFN1A1 genes. Genes Chromosomes Cancer. 2005 Jan; 42(1):82-6.
    View in: PubMed
    Score: 0.002
  118. Laryngectomy for fungal abscesses of the larynx. Otolaryngol Head Neck Surg. 2004 Dec; 131(6):1007-8.
    View in: PubMed
    Score: 0.002
  119. Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis. Brain. 2004 May; 127(Pt 5):996-1008.
    View in: PubMed
    Score: 0.001
  120. Prompt versus preemptive intervention for EBV lymphoproliferative disease. Blood. 2004 May 15; 103(10):3979-81.
    View in: PubMed
    Score: 0.001
  121. Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome. Biol Blood Marrow Transplant. 2003 Nov; 9(11):698-705.
    View in: PubMed
    Score: 0.001
  122. Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases. Leuk Lymphoma. 1993 Jul; 10(4-5):299-306.
    View in: PubMed
    Score: 0.001
  123. Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen. Bone Marrow Transplant. 2003 Jun; 31(11):981-6.
    View in: PubMed
    Score: 0.001
  124. Successful second bone marrow transplantation in a patient with myositis ossificans progressiva and aplastic anemia. Am J Pediatr Hematol Oncol. 1983; 5(4):337-40.
    View in: PubMed
    Score: 0.001
  125. Human cyclic neutropenia transferred by allogeneic bone marrow grafting. Blood. 1982 Dec; 60(6):1263-6.
    View in: PubMed
    Score: 0.001
  126. Energy expenditure in children undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002 Jul; 30(2):125-30.
    View in: PubMed
    Score: 0.001
  127. Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL. Cytotherapy. 2002; 4(3):253-8.
    View in: PubMed
    Score: 0.001
  128. Use of antithymocyte globulin for treatment of steroid-refractory acute graft-versus-host disease: an international practice survey. Bone Marrow Transplant. 2001 Nov; 28(10):945-50.
    View in: PubMed
    Score: 0.001
  129. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. J Clin Oncol. 2001 May 15; 19(10):2696-704.
    View in: PubMed
    Score: 0.001
  130. Improved cerebrovascular patency following therapy in patients with sickle cell disease: initial results in 4 patients who received HLA-identical hematopoietic stem cell allografts. Ann Neurol. 2001 Feb; 49(2):222-9.
    View in: PubMed
    Score: 0.001
  131. Tacrolimus clearance is age-dependent within the pediatric population. Bone Marrow Transplant. 2000 Sep; 26(6):601-5.
    View in: PubMed
    Score: 0.001
  132. Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease. Hum Gene Ther. 2000 Jul 01; 11(10):1465-75.
    View in: PubMed
    Score: 0.001
  133. Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector. Hum Gene Ther. 2000 Jul 01; 11(10):1477-88.
    View in: PubMed
    Score: 0.001
  134. CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood. 2000 Feb 15; 95(4):1502-5.
    View in: PubMed
    Score: 0.001
  135. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant. 1999 Feb; 23(3):277-82.
    View in: PubMed
    Score: 0.001
  136. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood. 1998 Sep 01; 92(5):1549-55.
    View in: PubMed
    Score: 0.001
  137. Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease. Hum Gene Ther. 1998 May 20; 9(8):1237-50.
    View in: PubMed
    Score: 0.001
  138. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet. 1997 Sep 13; 350(9080):767-71.
    View in: PubMed
    Score: 0.001
  139. A pilot study of continuous infusion Ara-C in combination with rhG-CSF in relapsed childhood acute myeloid leukemia. Leuk Lymphoma. 1997 Aug; 26(5-6):589-93.
    View in: PubMed
    Score: 0.001
  140. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count. Leukemia. 1997 Feb; 11(2):206-11.
    View in: PubMed
    Score: 0.001
  141. XYY syndrome in children with acute lymphoblastic leukemia. Med Pediatr Oncol. 1997 Jan; 28(1):6-8.
    View in: PubMed
    Score: 0.001
  142. NCCN pediatric osteosarcoma practice guidelines. The National Comprehensive Cancer Network. Oncology (Williston Park). 1996 Dec; 10(12):1799-806, 1812.
    View in: PubMed
    Score: 0.001
  143. Transfer of marker genes into hemopoietic progenitor cells. Cytokines Mol Ther. 1996 Sep; 2(3):193-200.
    View in: PubMed
    Score: 0.001
  144. Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemia. Leukemia. 1996 Aug; 10(8):1296-302.
    View in: PubMed
    Score: 0.001
  145. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med. 1996 May; 2(5):551-5.
    View in: PubMed
    Score: 0.001
  146. Use of double marking with retroviral vectors to determine rate of reconstitution of untreated and cytokine expanded CD34+ selected marrow cells in patients undergoing autologous bone marrow transplantation. Hum Gene Ther. 1996 Mar 20; 7(5):655-67.
    View in: PubMed
    Score: 0.001
  147. Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors. Bone Marrow Transplant. 1996 Feb; 17(2):243-7.
    View in: PubMed
    Score: 0.001
  148. Use of gene marking in bone marrow transplantation. Cancer Detect Prev. 1996; 20(2):108-13.
    View in: PubMed
    Score: 0.001
  149. L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins. Leukemia. 1995 Oct; 9(10):1680-4.
    View in: PubMed
    Score: 0.001
  150. Response of steroid-resistant graft-versus-host disease to lymphoblast antibody CBL1. Lancet. 1995 Sep 23; 346(8978):805-6.
    View in: PubMed
    Score: 0.001
  151. Enteral nutrition support in a child after bone marrow transplantation. Nutr Clin Pract. 1995 Aug; 10(4):140-3.
    View in: PubMed
    Score: 0.001
  152. Psychological effects of bone marrow transplantation on children and adolescents: preliminary report of a longitudinal study. Bone Marrow Transplant. 1995 Jun; 15(6):829-35.
    View in: PubMed
    Score: 0.001
  153. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet. 1995 Jan 07; 345(8941):9-13.
    View in: PubMed
    Score: 0.001
  154. Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J Haematol. 1995 Jan; 89(1):98-103.
    View in: PubMed
    Score: 0.001
  155. Pulmonary insufficiency complicating therapy with high dose cytosine arabinoside in five pediatric patients with relapsed acute myelogenous leukemia. Cancer. 1994 Oct 01; 74(7):1953-8.
    View in: PubMed
    Score: 0.001
  156. Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol. 1994 Sep; 12(9):1939-45.
    View in: PubMed
    Score: 0.001
  157. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood. 1994 Jul 15; 84(2):380-3.
    View in: PubMed
    Score: 0.001
  158. Childhood acute myeloid leukemia in mice with severe combined immunodeficiency. Blood. 1994 Jul 01; 84(1):20-6.
    View in: PubMed
    Score: 0.001
  159. Diffuse alveolar hemorrhage associated with Mycoplasma hominis respiratory tract infection in a bone marrow transplant recipient. Chest. 1994 Jun; 105(6):1891-2.
    View in: PubMed
    Score: 0.001
  160. Gene marking and autologous bone marrow transplantation. Ann N Y Acad Sci. 1994 May 31; 716:204-14; discussion 214-5, 225-7.
    View in: PubMed
    Score: 0.001
  161. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors. Bone Marrow Transplant. 1994 May; 13(5):571-5.
    View in: PubMed
    Score: 0.001
  162. Assessment of the efficacy of purging by using gene marked autologous marrow transplantation for children with AML in first complete remission. Hum Gene Ther. 1994 Apr; 5(4):481-99.
    View in: PubMed
    Score: 0.001
  163. Radiation-induced bone abnormalities after bone marrow transplantation for childhood leukemia. Radiology. 1994 Apr; 191(1):231-5.
    View in: PubMed
    Score: 0.001
  164. Epstein-Barr infection after bone marrow transplantation. Blood. 1994 Mar 15; 83(6):1706-8.
    View in: PubMed
    Score: 0.001
  165. Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts. Hum Gene Ther. 1994 Mar; 5(3):381-97.
    View in: PubMed
    Score: 0.001
  166. Bronchiolitis obliterans organizing pneumonia (BOOP) in children after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1994 Feb; 13(2):221-3.
    View in: PubMed
    Score: 0.001
  167. Gene transfer and bone marrow transplantation. Cold Spring Harb Symp Quant Biol. 1994; 59:691-7.
    View in: PubMed
    Score: 0.001
  168. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet. 1993 Nov 06; 342(8880):1134-7.
    View in: PubMed
    Score: 0.001
  169. Correction of Duncan's syndrome by allogeneic bone marrow transplantation. Lancet. 1993 Sep 04; 342(8871):587-8.
    View in: PubMed
    Score: 0.001
  170. High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas. J Clin Oncol. 1993 Aug; 11(8):1458-65.
    View in: PubMed
    Score: 0.001
  171. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med. 1993 Jul 29; 329(5):314-9.
    View in: PubMed
    Score: 0.001
  172. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet. 1993 Jan 09; 341(8837):85-6.
    View in: PubMed
    Score: 0.001
  173. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood. 1992 Dec 15; 80(12):3182-8.
    View in: PubMed
    Score: 0.001
  174. Diagnosis and treatment of the most common solid tumors in childhood. Prim Care. 1992 Dec; 19(4):871-89.
    View in: PubMed
    Score: 0.001
  175. Leukemias and lymphomas in children. Prim Care. 1992 Dec; 19(4):853-69.
    View in: PubMed
    Score: 0.001
  176. An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer. Blood. 1992 May 15; 79(10):2694-700.
    View in: PubMed
    Score: 0.001
  177. Current strategies for treatment of acute myeloid leukemia at St Jude Children's Research Hospital. Leukemia. 1992; 6 Suppl 2:39-43.
    View in: PubMed
    Score: 0.001
  178. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group. Leukemia. 1992; 6 Suppl 2:162-6.
    View in: PubMed
    Score: 0.001
  179. Biochemical interactions between methotrexate and 1-beta-D-arabinofuranosylcytosine in hematopoietic cells of children: a Pediatric Oncology Group study. Cancer Chemother Pharmacol. 1990; 27(1):60-6.
    View in: PubMed
    Score: 0.001
  180. Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remission. Blut. 1988 Jul; 57(1):7-13.
    View in: PubMed
    Score: 0.000
  181. Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T-cell leukemia. Cancer. 1987 Nov 15; 60(10):2366-71.
    View in: PubMed
    Score: 0.000
  182. Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes. J Clin Oncol. 1987 Nov; 5(11):1822-6.
    View in: PubMed
    Score: 0.000
  183. Bone marrow transplantation for acute nonlymphoblastic leukemia during first complete remission. An analysis of prognostic factors. Transplantation. 1987 May; 43(5):650-3.
    View in: PubMed
    Score: 0.000
  184. Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood. 1987 Apr; 69(4):1015-20.
    View in: PubMed
    Score: 0.000
  185. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission. Transplantation. 1987 Mar; 43(3):389-92.
    View in: PubMed
    Score: 0.000
  186. A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone. Transplant Proc. 1987 Feb; 19(1 Pt 3):2605-7.
    View in: PubMed
    Score: 0.000
  187. Peripheral T-cell lymphoma. A case report demonstrating morphologic heterogeneity and progression, and atypical immune reactions. Cancer. 1986 Jun 15; 57(12):2329-42.
    View in: PubMed
    Score: 0.000
  188. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood. 1986 Jan; 67(1):177-81.
    View in: PubMed
    Score: 0.000
  189. Novantrone for childhood malignant solid tumors. A pediatric oncology group phase II study. Invest New Drugs. 1986; 4(1):43-8.
    View in: PubMed
    Score: 0.000
  190. Peripheral T cell lymphoma: immunologic and cell-kinetic observations associated with morphological progression. Blood. 1985 Oct; 66(4):980-9.
    View in: PubMed
    Score: 0.000
  191. Bone marrow transplantation for acute leukemia. Haematol Blood Transfus. 1985; 29:39-41.
    View in: PubMed
    Score: 0.000
  192. Outcome of bone marrow transplantation in patients with extramedullary involvement of acute leukemia. Blut. 1984 Feb; 48(2):75-9.
    View in: PubMed
    Score: 0.000
  193. Bone marrow ablation followed by allogeneic marrow grafting during first complete remission of acute nonlymphocytic leukemia. Blood. 1983 Mar; 61(3):439-42.
    View in: PubMed
    Score: 0.000
  194. Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders. Ann Neurol. 1980 Jan; 7(1):58-64.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.